CTB: Small HNX pump-maker; mid-cycle EV/EBITDA supports fair value but upside is marginal and illiquidity raises execution risk
Intrinsic value VND 16,448 vs market VND 16,100 — implied upside 2.2% (confidence: very_low).
Business Overview
Công ty Cổ phần Chế tạo Bơm Hải Dương (CTB) is an HNX-listed heavy-industry manufacturer focused on pump and rotating-equipment fabrication (small-cap, cyclical exposure). The company has 20,800,000 issued shares and trades with limited liquidity (avg volume 2w: 950 shares). CTB's product mix and customer base expose it to capital-spend cycles in industry and infrastructure. It sits in the 'Công nghiệp nặng' ICB3 group and faces the typical Vietnamese accounting and working-capital quirks under VAS (capitalisation policies, different treatment of provisions).
Investment Thesis
1) Valuation versus sector and model constraints: Our EV/EBITDA mid-cycle model yields an intrinsic value of VND 16,448 per share using a fair EV/EBITDA of 5.23 (own history) applied to a mid-cycle EBITDA. The sector EV/EBITDA is higher at 9.14, and CTB's latest reported EV/EBITDA is 5.6889, implying the company is valued below sector multiples but only modestly above the model's fair multiple. The calibrated model increased a raw intrinsic value of VND 14,472 to VND 16,448 via isotonic calibration, reflecting the limited dataset and a sanity flag for illiquidity.
2) Earnings and margin profile: CTB reports an EBIT margin of 8.66%, gross margin 19.68% and net profit margin 6.61%. ROE is 12.5% and ROA 6.0%, while P/E is 8.6x and P/B 1.05x — metrics consistent with a low-growth, asset-heavy manufacturer. Revenue has fallen from VND 991.3 bn in 2023 to VND 584.4 bn in 2025; net profit declined from VND 50.8 bn in 2023 to VND 38.6 bn in 2025, indicating margin pressure and top-line contraction across the three-year window.
3) Quality, governance and liquidity: Earnings quality is high at 94/100, and there are no forensic M-Score flags in the input data. However, ownership is dispersed among multiple individuals (largest shareholders ~4.9%, 4.8%, 4.6%, 4.5%) and a small institutional stake (AFC Umbrella Fund 3.88%), which leaves limited strategic sponsors and low free-float depth for active market-making. Foreign room remains available at 10,323,893 shares but market microstructure risk persists given the 2-week average volume of 950 shares.
4) Practical conclusion: The implied upside (2.2%) is economically negligible once execution and liquidity risk are considered. The valuation relies on a mid-cycle EBITDA and a fair EV/EBITDA below the sector median; given the model confidence is 'very_low' and the calibration step materially lifted the raw intrinsic value, the margin of safety is thin and warrants caution.
Valuation Commentary
EV/EBITDA mid-cycle: apply a fair EV/EBITDA multiple to a mid-cycle EBITDA then subtract net debt to derive equity value per share.
- Mid-cycle EBITDA used by model: VND 63.9 bn (model input 63,883,737,552).
- Fair EV/EBITDA applied: 5.23 (own_history); sector EV/EBITDA: 9.14.
- Net debt in model: VND 33.1 bn (model input 33,056,295,149).
- Raw intrinsic value before calibration: VND 14,472 (model_inputs.raw_intrinsic_value).
- Calibration (isotonic) raised intrinsic value to VND 16,448; model confidence labeled very_low and a sanity flag 'illiquid' is present.
The model yields a marginal implied upside of 2.2% to VND 16,448, but confidence is very low and the model required isotonic calibration from a raw intrinsic value of VND 14,472. Given the illiquidity flag and limited trading volumes, the small upside is unlikely to compensate for execution and market-impact risk; our conviction in the intrinsic estimate is therefore weak.
Bull vs Bear
- Valuation gap to sector: CTB's EV/EBITDA of 5.69 is below sector EV/EBITDA 9.14, leaving scope for multiple re-rating if sector multiples normalize.
- Relatively attractive earnings multiples: P/E 8.6x and P/B 1.05x with dividend yield 9.32% could appeal to income-seeking investors if cash payouts remain.
- High earnings quality score (94/100) and absence of forensic red flags support reported profitability and cash conversion.
- Top-line contraction: Revenue fell from VND 991.3 bn (2023) to VND 584.4 bn (2025), and net profit dropped from VND 50.8 bn to VND 38.6 bn over the same period, indicating shrinking scale and margin pressure.
- Model uncertainty and illiquidity: intrinsic value calibration and 'very_low' model confidence plus 'illiquid' sanity flag increase valuation risk and execution cost (avg volume 2w: 950).
- Concentrated operational risk in a cyclical heavy-industry business; sector cyclicality could compress demand and further depress margins.
- Limited strategic shareholders: largest holders are individuals with stakes under 5%, reducing catalyst potential from active institutional ownership (largest institution 3.88%).
Sector Context
CTB operates in Vietnam's heavy industry (ICB3: Công nghiệp nặng) where demand is tied to infrastructure spend, industrial capex and commodity cycles. Sector-wide EV/EBITDA is 9.14 (peer set count: 385), implying CTB trades below the sector multiple. Peers include higher-upside names (top peers showing ~40.3% implied upside in our peer screen) but those comparables often have different scale, growth prospects or visibility. Regulatory and macro considerations in Vietnam matter: VAS accounting can make cross-company comparability noisy, State Bank of Vietnam credit quotas affect upstream/downstream customers, and SOE dividend/payout mandates can influence capital allocation for larger group members. For small caps like CTB, market microstructure and foreign ownership mechanics (foreign_room: 10,323,893 shares available) matter more for realized returns than headline multiples.
Risk Factors
- Demand cyclicality: end-market investment slowdowns could further reduce revenues (revenue down 41% from VND 991.3 bn in 2023 to VND 584.4 bn in 2025).
- Liquidity & market-impact risk: 2-week average volume is only 950 shares and HNX trading makes exits costly; model flagged 'illiquid'.
- Model and data uncertainty: valuation relies on calibrated mid-cycle assumptions (raw intrinsic VND 14,472 -> calibrated VND 16,448) and confidence is very_low.
- Concentration of operational risk: top shareholders are small individual stakes (largest 4.93%), limiting strategic support and potential for governance-driven turnarounds.
- Margin pressure and profitability trends: declining net profit (VND 50.8 bn -> VND 38.6 bn) suggests margin or pricing stress that could persist.
- Macroeconomic/regulatory shocks: shifts in credit growth managed by the SBV or sudden changes in infrastructure spending could quickly impact order books.
Catalysts
- Stabilization or recovery in industrial capex that reverses the revenue decline seen 2023-25.
- Any visible improvement in quarterly order intake and sequential EBITDA recovery toward the model's mid-cycle target.
- Increased institutional interest or a larger committed investor that reduces liquidity premium (currently small institutional stake 3.88%).
- Corporate actions: clearer dividend policy or share buybacks that reduce free float and increase per-share cash return.
Forensic Assessment
There are no M-Score values or forensic red flags in the input data and the earnings quality metric is high at 94/100, indicating reported earnings are likely high quality under available disclosures. That said, absence of flagged manipulation does not eliminate typical VAS-related comparability issues (capitalisation, provisions) and the small shareholder base means transparency and governance remain watchpoints.
Track Record
The team's historical model record for this coverage universe spans 12 years with a hit rate of 72.7% (model directional calls matched subsequent year moves in ~72.7% of years) and an average upside of 64.7% when calls were correct. Past performance shows reasonable directional skill, but the model's short-term calibration and the 'very_low' confidence on this specific valuation warrant caution when relying on the point estimate.
Written by a language model on 2026-08-10 from this page’s own model outputs and financial statements, and may quote figures from that date. Descriptive analysis, not investment advice — no buy, sell or hold recommendation is given or implied.